-
1.
公开(公告)号:US20190209606A1
公开(公告)日:2019-07-11
申请号:US16333434
申请日:2017-09-14
Applicant: UNIVERSITY OF UTAH RESEARCH FOUNDATION
Inventor: Hamidreza GHANDEHARI , Siam OOTTAMASATHIEN , Mark Martin JENSEN , Joseph CAPPELLO , Wanjian JIA , Glenn D. PRESTWICH
IPC: A61K31/737 , A61K9/00 , A61K9/06 , A61K31/728 , A61K47/42 , A61K45/06 , A61P29/00
CPC classification number: A61K31/737 , A61K9/0019 , A61K9/06 , A61K31/728 , A61K45/06 , A61K47/36 , A61K47/42 , A61P29/00 , C07K14/78
Abstract: Described herein are in situ gelling compositions. The compositions include an anti-inflammatory polysaccharide and a gelling polymer, wherein the composition is a liquid prior to administration to a subject but converts to a gel upon administration to the subject. The compositions described herein have numerous applications with respect to the local treatment (reduction or prevention) of inflammation and/or tissue damage.
-
公开(公告)号:US20160361349A1
公开(公告)日:2016-12-15
申请号:US15205093
申请日:2016-07-08
Applicant: University of Utah Research Foundation
Inventor: Glenn D. PRESTWICH , Siam OOTTAMASATHEIN , Thomas P. KENNEDY
IPC: A61K31/737 , A61Q11/00 , A61K8/73 , A61K45/06
CPC classification number: A61K8/735 , A61K31/737 , A61K45/06 , A61Q11/00 , A61Q19/08 , A61K2300/00
Abstract: Described herein is the use of partially and fully sulfated hyaluronan or the pharmaceutically acceptable salt or ester thereof for therapeutic and cosmetic applications as well as the treatment of a number of systemic, dermatological, periodontal, ophthalmic, and urological inflammatory diseases.
-